Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2496044

CN(C)C(=O)CC[C@H](N)C(=O)N(C)C.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 8/20 0.41
DPP9 Q86TI2 3/20 0.41
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA4 P43681 1/20 0.36
DPP7 Q9UHL4 5/20 0.34
GABRP O00591 2/20 0.33
GABRD O14764 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRB1 P18505 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33
GABRB2 P47870 2/20 0.33
GABRA4 P48169 2/20 0.33
GABRE P78334 2/20 0.33
GABRA6 Q16445 2/20 0.33
GABRG1 Q8N1C3 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13913806 0.88 DPP4 (0.44) DPP4DPP9CHRNB2CHRNB4CHRNA4
SCHEMBL13913822 0.88 DPP4 (0.44) DPP4DPP9CHRNB2CHRNB4CHRNA4
Trifluoroacetic Acid SCHEMBL2493278 0.87 ALOX15 (0.48) DPP4DPP9DPP7GRM8GRM6
Trifluoroacetic Acid SCHEMBL2493179 0.83 DPP8 (0.36) DPP4DPP9DPP7GRIK1DPP8
Trifluoroacetic Acid SCHEMBL9656367 0.79 DPP4 (0.35) DPP4DPP9DPP7SLC1A1DPP8
Trifluoroacetic Acid SCHEMBL2500137 0.79 DPP4 (0.35) DPP4DPP9DPP7SLC1A1DPP8
Trifluoroacetic Acid SCHEMBL2496872 0.79 DPP8 (0.38) DPP4DPP9DPP7SLC1A3SLC1A2
Trifluoroacetic Acid SCHEMBL2493520 0.79 BHMT (0.38) DPP4DPP9DPP7DPP8KCNH2
SCHEMBL16240926 0.76 DPP4 (0.62) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL16240927 0.76 DPP4 (0.62) DPP4DPP9GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 DPP4 2704/4885DPP9 3556/4885CHRNB2 1279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.